Ernexa Therapeutics Inc. (ERNA) Accumulated Expenses (2010 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Accumulated Expenses came in at $497000.0 in Q1 2026, up 4041.67% YoY from $12000.0 in Q1 2025, and down 44.65% on a QoQ basis from $898000.0 in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Accumulated Expenses (2010 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 17 years of Accumulated Expenses data on file, last reported at $497000.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 4041.67% year-over-year to $497000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $497000.0 (up 4041.67% YoY) and the FY2025 annual result came in at $898000.0, up 7383.33% from the prior year.
- Accumulated Expenses fell to $497000.0 in Q1 2026, from $898000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $5.0 million in Q3 2023 to a low of $12000.0 in Q4 2024.
- A 5-year average of $1.4 million and a median of $938000.0 in 2025 frame the typical range for Accumulated Expenses.
- The widest YoY moves for Accumulated Expenses: up 7383.33% in 2025, down 99.36% in 2025.
- Tracing ERNA's Accumulated Expenses over 5 years: stood at $1.1 million in 2022, then tumbled by 83.47% to $176000.0 in 2023, then sank by 93.18% to $12000.0 in 2024, then soared by 7383.33% to $898000.0 in 2025, then plunged by 44.65% to $497000.0 in 2026.
- The last three Accumulated Expenses figures came in at $497000.0 (Q1 2026), $898000.0 (Q4 2025), and $859000.0 (Q3 2025), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 497,000.00 |
| Dec 31, 2025 | 898,000.00 |
| Sep 30, 2025 | 859,000.00 |
| Jun 30, 2025 | 938,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 176,000.00 |
| Sep 30, 2023 | 5.02 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 3.82 Mn |
| Mar 31, 2022 | 637,000.00 |
| Dec 31, 2021 | 656,000.00 |
| Sep 30, 2021 | 589,652.00 |